Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hatem A. Abuelizz"'
Publikováno v:
Acta Chromatographica. 32:170-178
The US Food and Drug Administration (FDA) has affirmed the use of letrozole (LTZ) combined with palbociclib (PLB) to treat breast malignant tumor growth in postmenopausal women. A straightforward and extremely sensitive reversed-phase high-performanc
Autor:
Hatem A. Abuelizz, Nasser S. Al-Shakliah, Rashad Al-Salahi, El Hassane Anouar, Mohamed Marzouk
Publikováno v:
Open Chemistry, Vol 18, Iss 1, Pp 740-751 (2020)
Previously, a series of pyridotriazolopyrimidines (1–6) were synthesized and fully described. The target compounds (1–6) were evaluated for their cytotoxicity against MCF-7, HepG2, WRL 68, and A549 (breast adenocarcinoma, hepatocellular carcinoma
Publikováno v:
Saudi Pharmaceutical Journal, Vol 27, Iss 8, Pp 1075-1084 (2019)
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal : SPJ
A Microemulsion Electrokinetic Chromatography method coupled with diode array detector (MEEKC-DAD) was developed for the first time and found to be efficient, sensitive, and selective for the simultaneous analysis of Trifluridine (FTD), and its metab
Autor:
Mohamed Marzouk, I. T. Ibrahim, Rashad Al-Salahi, Hatem A. Abuelizz, Abdulrahman I. Alharthi, Khalid A. Alburikan, M. A. Motaleb, Moustapha E. Moustapha
Publikováno v:
Saudi Pharmaceutical Journal, Vol 26, Iss 8, Pp 1120-1126 (2018)
3-Benzyl-2-((3-methoxybenzyl)thio)benzo[g]quinazolin-4(3H)-one was previously synthesized and proved by physicochemical analyses (HRMS, 1H and 13C NMR). The target compound was examined for its radioactivity and the results showed that benzo[g]quinaz
Autor:
Hatem A. Abuelizz, Ali Alhoshani, Amany Z. Mahmoud, Iman S. Issa, Huda S. Al-Salem, Arifuzzaman, A. F. M. Motiur Rahman
Publikováno v:
Applied Sciences
Volume 10
Issue 11
Applied Sciences, Vol 10, Iss 3669, p 3669 (2020)
Volume 10
Issue 11
Applied Sciences, Vol 10, Iss 3669, p 3669 (2020)
Developing anticancer therapeutics with no/few side effects is a challenge for medicinal chemists. The absence of antibacterial activity of an anticancer drug removes its detrimental effect toward intestinal flora and therefore leads to reduced side
Autor:
Naglaa I. Abdel-Aziz, Alaa A.-M. Abdel-Aziz, Hatem A. Abuelizz, Magda A.-A. El-Sayed, Walaa M. El-Husseiny, Adel S. El-Azab
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 33, Iss 1, Pp 199-209 (2018)
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry
A new series of 4,6-disubstituted 2-(4-(dimethylamino)styryl)quinoline 4a,b–9a,b was synthesized by the reaction of 2-(4-(dimethylamino)styryl)-6-substituted quinoline-4-carboxylic acids 3a,b with thiosemicarbazide, p-hydroxybenzaldehyde, ethylcyan
Autor:
Ahmed H. Bakheit, Hanan A. A. Taie, Hatem A. Abuelizz, Rashed N Herqash, Abdulrahman A. Almehizia, Rashad Al-Salahi, Mohamed Marzouk
Publikováno v:
Pharmacological reports : PR. 71(4)
Background Oxidative stress and related diseases resulting from the overproduction of free radicals can be counteracted by designing and developing novel antioxidative agents that can protect the human body against the damage caused by free radicals.